Identity
- Security key
- 18221
- Ticker
- LTRN
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-06-11
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- LTRN
Detail
Enriched 2026-08-14 20:47
- Market cap
- $33,939,328.36
- Shares outstanding (class)
- 12,758,872
- Shares outstanding (weighted)
- 12,759,146
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 16
- Location
- DALLAS, TX
- Homepage
- https://www.lanternpharma.com
- Description
Lantern Pharma Inc is a biopharmaceutical company focused on developing oncology drug candidates using its artificial intelligence platform. The company utilizes its proprietary RADR platform to identify, develop, and advance small molecule therapies and antibody-drug conjugates, with a pipeline that includes three lead small molecule drug candidates (LP-300, LP-184, and LP-284) targeting solid tumors and blood cancers. It also advances programs through its subsidiary focused on central nervous system and brain cancers.